Cargando…
Anti-leukemia activity of human gamma delta T cells
Two recently published articles from Siegers and colleagues detail both a novel human gamma delta T cell (GDTc) expansion protocol and a bioluminescent xenograft model of Ph(+) leukemia, in which GDTc adoptive therapy was tested. Additionally, B-cell chronic lymphocytic leukemia-derived cells were n...
Autor principal: | Siegers, Gabrielle M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376996/ https://www.ncbi.nlm.nih.gov/pubmed/22720255 http://dx.doi.org/10.4161/onci.1.2.18231 |
Ejemplares similares
-
Non-V delta 2 gamma delta T lymphocytes as effectors of cancer immunotherapy
por: Fisher, Jonathan, et al.
Publicado: (2014) -
Anti-Leukemia Activity of In Vitro-Expanded Human Gamma Delta T Cells in a Xenogeneic Ph(+) Leukemia Model
por: Siegers, Gabrielle M., et al.
Publicado: (2011) -
Human Gamma Delta T Regulatory Cells in Cancer: Fact or Fiction?
por: Wesch, Daniela, et al.
Publicado: (2014) -
Understanding anti-leukemia responses to donor lymphocyte infusion
por: Bachireddy, Pavan, et al.
Publicado: (2014) -
Type 2 innate lymphoid cells: a novel actor in anti-melanoma immunity
por: Jacquelot, Nicolas, et al.
Publicado: (2021)